MEDI-528: Development discontinued

AstraZeneca disclosed in its 3Q11 earnings that it discontinued development of MEDI-528 due

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE